Stapokibart
CQMU-2025-215
Unknown mab active
Quick answer
Stapokibart for Primary Cutaneous Amyloidosis is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Primary Cutaneous Amyloidosis
- Phase
- Unknown
- Modality
- mab
- Status
- active